Loading...
Biostage, Inc.
BSTG•PNK
HealthcareBiotechnology
$4.03
$0.03(0.75%)
Biostage, Inc. (BSTG) Stock Overview
Explore Biostage, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for BSTGStats details for BSTG are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for BSTGAnalyst Recommendations details for BSTG are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company is engaged in developing Biostage Esophageal Implant for the treating esophageal cancer. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.
CEO
Mr. Junli He
Employees
7
Headquarters
84 October Hill Road, Holliston, MA
Founded
2013